Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Brendan Murphy Everett, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R56HL134810 (EVERETT, BRENDAN M) Sep 22, 2018 - Aug 31, 2020
    Inflammation Reduction to Prevent Atrial Fibrillation (CIRT-AF)
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Pandey A, Vaduganathan M, Patel KV, Ayers C, Ballantyne CM, Kosiborod MN, Carnethon M, DeFilippi C, McGuire DK, Khan SS, Caughey MC, de Lemos JA, Everett BM. Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes. JACC Heart Fail. 2021 Mar; 9(3):215-223. PMID: 33422434.
    Citations:    Fields:    
  2. Feldman CH, Speyer C, Ashby R, L Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH. Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. Arthritis Care Res (Hoboken). 2021 01; 73(1):146-157. PMID: 31628721.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  3. Choi MY, Li D, Feldman CH, Yoshida K, Guan H, Kim SC, Everett BM, Costenbader KH. Comparative Risks of Cardiovascular Disease Events among SLE Patients receiving Immunosuppressive Medications. Rheumatology (Oxford). 2020 Dec 28. PMID: 33369672.
    Citations:    Fields:    
  4. Everett BM, MacFadyen JG, Thuren T, Libby P, Glynn RJ, Ridker PM. Inhibition of Interleukin-1ß and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial. J Am Coll Cardiol. 2020 10 06; 76(14):1660-1670. PMID: 33004131.
    Citations: 4     Fields:    Translation:Humans
  5. Barbhaiya M, Feldman CH, Chen SK, Guan H, Fischer MA, Everett BM, Costenbader KH. Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients. Arthritis Care Res (Hoboken). 2020 10; 72(10):1431-1439. PMID: 32475049.
    Citations:    Fields:    Translation:Humans
  6. Sumarsono A, Buckley LF, Machado SR, Wadhera RK, Warraich HJ, Desai RJ, Everett BM, McGuire DK, Fonarow GC, Butler J, Pandey A, Vaduganathan M. Medicaid Expansion and Utilization of Antihyperglycemic Therapies. Diabetes Care. 2020 11; 43(11):2684-2690. PMID: 32887711.
    Citations:    Fields:    
  7. Ajala ON, Everett BM. Targeting Inflammation to Reduce Residual Cardiovascular Risk. Curr Atheroscler Rep. 2020 Sep 03; 22(11):66. PMID: 32880743.
    Citations: 1     Fields:    
  8. Fralick M, Kim SC, Schneeweiss S, Everett BM, Glynn RJ, Patorno E. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020 08 25; 370:m2812. PMID: 32843476.
    Citations: 2     Fields:    Translation:Humans
  9. Das SR, Everett BM, Birtcher KK, Brown JM, Januzzi JL, Kalyani RR, Kosiborod M, Magwire M, Morris PB, Neumiller JJ, Sperling LS. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 09 01; 76(9):1117-1145. PMID: 32771263.
    Citations: 9     Fields:    Translation:Humans
  10. Everett BM, Moorthy MV, Tikkanen JT, Cook NR, Albert CM. Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death. Circulation. 2020 Sep 22; 142(12):1148-1158. PMID: 32700639.
    Citations:    Fields:    
  11. Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford). 2020 03 01; 59(3):495-504. PMID: 31321417.
    Citations: 3     Fields:    Translation:Humans
  12. Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus. Rheumatology (Oxford). 2020 03 01; 59(3):697. PMID: 31504932.
    Citations:    Fields:    
  13. Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, Rao DA, Ritter SY, Rutherford A, Sparks JA, Stratton J, Suh DH, Tedeschi SK, Vanni KMM, Paynter NP, Ridker PM. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Ann Intern Med. 2020 03 17; 172(6):369-380. PMID: 32066146.
    Citations: 17     Fields:    Translation:Humans
  14. Sumarsono A, Everett BM, McGuire DK, Fonarow GC, Butler J, Pandey A, Vaduganathan M. Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017. JAMA Intern Med. 2020 Jan 01; 180(1):141-144. PMID: 31566649.
    Citations: 4     Fields:    
  15. Speyer CB, Li D, Guan H, Yoshida K, Stevens E, Jorge AM, Everett BM, Feldman CH, Costenbader KH. Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores. Rheumatol Int. 2020 Feb; 40(2):257-261. PMID: 31784790.
    Citations: 3     Fields:    Translation:Humans
  16. Brown JM, Everett BM. Cardioprotective diabetes drugs: what cardiologists need to know. Cardiovasc Endocrinol Metab. 2019 Dec; 8(4):96-105. PMID: 31942550.
    Citations: 2     
  17. Chen SK, Barbhaiya M, Solomon DH, Guan H, Yoshida K, Feldman CH, Everett BM, Costenbader KH. Atrial Fibrillation/flutter Hospitalizations among US Medicaid Recipients with and without Systemic Lupus Erythematosus. J Rheumatol. 2020 09 01; 47(9):1359-1365. PMID: 31676703.
    Citations: 1     Fields:    
  18. Segar MW, Vaduganathan M, Patel KV, McGuire DK, Butler J, Fonarow GC, Basit M, Kannan V, Grodin JL, Everett B, Willett D, Berry J, Pandey A. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care. 2019 12; 42(12):2298-2306. PMID: 31519694.
    Citations: 14     Fields:    Translation:Humans
  19. Chen SK, Barbhaiya M, Fischer MA, Guan H, Yoshida K, Feldman CH, Costenbader KH, Everett BM. Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients. Semin Arthritis Rheum. 2019 12; 49(3):389-395. PMID: 31280938.
    Citations: 4     Fields:    Translation:Humans
  20. Everett BM. Residual Inflammatory Risk: A Common and Important Risk Factor for Recurrent Cardiovascular Events. J Am Coll Cardiol. 2019 05 21; 73(19):2410-2412. PMID: 31097160.
    Citations:    Fields:    Translation:Humans
  21. Aday AW, Everett BM. Dyslipidemia Profiles in Patients with Peripheral Artery Disease. Curr Cardiol Rep. 2019 04 22; 21(6):42. PMID: 31011836.
    Citations: 2     Fields:    Translation:Humans
  22. Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Circulation. 2019 04 02; 139(14):1741-1743. PMID: 30933621.
    Citations: 1     Fields:    Translation:Humans
  23. Libby P, Everett BM. Novel Antiatherosclerotic Therapies. Arterioscler Thromb Vasc Biol. 2019 04; 39(4):538-545. PMID: 30816799.
    Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
  24. Everett BM, Siddiqi HK. Heart Failure, the Inflammasome, and Interleukin-1ß: Prognostic and Therapeutic? J Am Coll Cardiol. 2019 03 12; 73(9):1026-1028. PMID: 30846096.
    Citations:    Fields:    Translation:Humans
  25. Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 2019 03 05; 139(10):1289-1299. PMID: 30586730.
    Citations: 61     Fields:    Translation:Humans
  26. Chen SK, Barbhaiya M, Fischer MA, Guan H, Lin TC, Feldman CH, Everett BM, Costenbader KH. Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population. Arthritis Care Res (Hoboken). 2019 01; 71(1):104-115. PMID: 29648687.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  27. Das SR, Everett BM, Birtcher KK, Brown JM, Cefalu WT, Januzzi JL, Kalyani RR, Kosiborod M, Magwire ML, Morris PB, Sperling LS. 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2018 12 18; 72(24):3200-3223. PMID: 30497881.
    Citations: 65     Fields:    Translation:Humans
  28. Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med. 2019 02 21; 380(8):752-762. PMID: 30415610.
    Citations: 145     Fields:    Translation:Humans
  29. Rezende PC, Everett BM, Brooks MM, Vlachos H, Orchard TJ, Frye RL, Bhatt DL, Hlatky MA. Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease. J Am Coll Cardiol. 2018 10 09; 72(15):1778-1786. PMID: 30286920.
    Citations: 2     Fields:    Translation:Humans
  30. Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur Heart J. 2018 10 07; 39(38):3499-3507. PMID: 30165610.
    Citations: 63     Fields:    Translation:HumansCellsPHPublic Health
  31. Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. Am Heart J. 2018 12; 206:80-93. PMID: 30342298.
    Citations: 43     Fields:    Translation:Humans
  32. Solomon DH, Glynn RJ, MacFadyen JG, Libby P, Thuren T, Everett BM, Ridker PM. Relationship of Interleukin-1ß Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial. Ann Intern Med. 2018 10 16; 169(8):535-542. PMID: 30242335.
    Citations: 6     Fields:    Translation:Humans
  33. Everett BM, Ridker PM. Reply: Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting. J Am Coll Cardiol. 2018 09 18; 72(12):1432-1433. PMID: 30213342.
    Citations:    Fields:    Translation:Humans
  34. Yu Z, Yang N, Everett BM, Frits M, Iannaccone C, Coblyn J, Weinblatt M, Shadick N, Solomon DH, Liao KP. Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis. Arthritis Rheumatol. 2018 09; 70(9):1392-1398. PMID: 29676517.
    Citations: 1     Fields:    Translation:Humans
  35. Barbhaiya M, Feldman CH, Guan H, Chen SK, Fischer MA, Solomon DH, Everett BM, Costenbader KH. Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2019 04; 48(5):840-846. PMID: 30205982.
    Citations: 4     Fields:    Translation:Humans
  36. Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, Lefkowitz M, Thuren T, Cornel JH. Inhibition of Interleukin-1ß by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease. J Am Coll Cardiol. 2018 05 29; 71(21):2405-2414. PMID: 29793629.
    Citations: 26     Fields:    Translation:Humans
  37. Than MP, Aldous SJ, Troughton RW, Pemberton CJ, Richards AM, Frampton CMA, Florkowski CM, George PM, Bailey S, Young JM, Cullen L, Greenslade JH, Parsonage WA, Everett BM, Peacock WF, Jaffe AS, Pickering JW. Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study. Clin Chem. 2018 07; 64(7):1044-1053. PMID: 29760219.
    Citations: 2     Fields:    Translation:Humans
  38. Aday AW, Everett BM. Statins in Peripheral Artery Disease: What Are We Waiting For? Circulation. 2018 04 03; 137(14):1447-1449. PMID: 29610126.
    Citations: 2     Fields:    Translation:Humans
  39. Everett BM, Donath MY, Pradhan AD, Thuren T, Pais P, Nicolau JC, Glynn RJ, Libby P, Ridker PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. J Am Coll Cardiol. 2018 05 29; 71(21):2392-2401. PMID: 29544870.
    Citations: 59     Fields:    Translation:Humans
  40. Patorno E, Goldfine AB, Schneeweiss S, Everett BM, Glynn RJ, Liu J, Kim SC. Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study. BMJ. 2018 02 06; 360:k119. PMID: 29437648.
    Citations: 35     Fields:    Translation:Humans
  41. Srivastava PK, Pradhan AD, Cook NR, Ridker PM, Everett BM. Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis. J Am Heart Assoc. 2017 12 23; 6(12). PMID: 29275373.
    Citations: 1     Fields:    Translation:Humans
  42. Srivastava PK, Everett BM. The Burden of a Heavy Heart. Clin Chem. 2018 01; 64(1):10-12. PMID: 29158253.
    Citations:    Fields:    
  43. Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018 01 27; 391(10118):319-328. PMID: 29146124.
    Citations: 150     Fields:    Translation:Humans
  44. Everett BM. Cardiac troponin: the next tool for cardiovascular disease prevention in ambulatory patients? Heart. 2018 06; 104(11):875-877. PMID: 29127184.
    Citations:    Fields:    Translation:Humans
  45. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017 09 21; 377(12):1119-1131. PMID: 28845751.
    Citations: 1285     Fields:    Translation:HumansPHPublic Health
  46. Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ. Effect of interleukin-1ß inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017 Oct 21; 390(10105):1833-1842. PMID: 28855077.
    Citations: 238     Fields:    Translation:Humans
  47. Barbhaiya M, Feldman CH, Guan H, Gómez-Puerta JA, Fischer MA, Solomon DH, Everett B, Costenbader KH. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 09; 69(9):1823-1831. PMID: 28598016.
    Citations: 12     Fields:    Translation:Humans
  48. Everett BM. Low-Density Lipoprotein Cholesterol and the On-Target Effects of Therapy: How Low Is Too Low? J Am Coll Cardiol. 2017 02 07; 69(5):483-485. PMID: 28153103.
    Citations: 1     Fields:    
  49. Everett BM, Ridker PM. Biomarkers for Cardiovascular Screening: Progress or Passé? Clin Chem. 2017 01; 63(1):248-251. PMID: 27903617.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  50. Everett BM, Hiatt WR. Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death. Circulation. 2016 Sep 06; 134(10):773-5. PMID: 27601559.
    Citations: 1     Fields:    Translation:Humans
  51. Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, Pennells L, Gao P, Burgess S, Freitag DF, Sweeting M, Wood AM, Cook NR, Judd S, Trompet S, Nambi V, Olsen MH, Everett BM, Kee F, Ärnlöv J, Salomaa V, Levy D, Kauhanen J, Laukkanen JA, Kavousi M, Ninomiya T, Casas JP, Daniels LB, Lind L, Kistorp CN, Rosenberg J, Mueller T, Rubattu S, Panagiotakos DB, Franco OH, de Lemos JA, Luchner A, Kizer JR, Kiechl S, Salonen JT, Goya Wannamethee S, de Boer RA, Nordestgaard BG, Andersson J, Jørgensen T, Melander O, Ballantyne ChM, DeFilippi Ch, Ridker PM, Cushman M, Rosamond WD, Thompson SG, Gudnason V, Sattar N, Danesh J, Di Angelantonio E. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016 10; 4(10):840-9. PMID: 27599814.
    Citations: 42     Fields:    Translation:Humans
  52. Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL. Sex Differences in Cardiac Troponin and the Risk of Death or Major Cardiovascular Events. J Am Coll Cardiol. 2016 08 30; 68(9):978-80. PMID: 27561773.
    Citations: 1     Fields:    Translation:Humans
  53. Maneze D, Everett B, Astorga C, Yogendran D, Salamonson Y. The Influence of Health Literacy and Depression on Diabetes Self-Management: A Cross-Sectional Study. J Diabetes Res. 2016; 2016:3458969. PMID: 27595113.
    Citations: 9     Fields:    Translation:Humans
  54. Lawler PR, Everett BM. Assessing the Effects of Diet and Behavior on Cardiovascular Disease: The Role of Biomarkers in Understanding Biology and Mechanism. Clin Chem. 2016 09; 62(9):1169-71. PMID: 27430707.
    Citations:    Fields:    Translation:Humans
  55. Everett BM. Cardiac troponin as a novel tool for cardiovascular risk prediction in ambulatory populations. Trends Cardiovasc Med. 2017 01; 27(1):41-47. PMID: 27422097.
    Citations: 2     Fields:    Translation:HumansCells
  56. Jiménez MC, Rexrode KM, Kotler G, Everett BM, Glynn RJ, Lee IM, Buring JE, Ridker PM, Sesso HD. Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women. Am J Hypertens. 2016 09; 29(9):1117-24. PMID: 27235695.
    Citations: 4     Fields:    Translation:Humans
  57. Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jørgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. 2016 Aug 07; 37(30):2428-37. PMID: 27174290.
    Citations: 34     Fields:    Translation:Humans
  58. Patorno E, Everett BM, Goldfine AB, Glynn RJ, Liu J, Gopalakrishnan C, Kim SC. Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study. Diabetes Obes Metab. 2016 08; 18(8):755-65. PMID: 27003762.
    Citations: 10     Fields:    Translation:Humans
  59. Srivastava PK, Pradhan AD, Cook NR, Ridker PM, Everett BM. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations. Am J Cardiol. 2016 Feb 01; 117(3):376-81. PMID: 26739393.
    Citations: 5     Fields:    Translation:Humans
  60. Everett BM, Brooks MM, Bhatt DL. Troponin in Stable Ischemic Heart Disease and Diabetes. N Engl J Med. 2015 11 12; 373(20):1978-9. PMID: 26559577.
    Citations: 1     Fields:    Translation:Humans
  61. Everett BM, Smith RJ, Hiatt WR. Reducing LDL with PCSK9 Inhibitors--The Clinical Benefit of Lipid Drugs. N Engl J Med. 2015 Oct 22; 373(17):1588-91. PMID: 26444323.
    Citations: 45     Fields:    Translation:Humans
  62. Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes. N Engl J Med. 2015 Aug 13; 373(7):610-20. PMID: 26267622.
    Citations: 48     Fields:    Translation:HumansCTClinical Trials
  63. Everett BM, Ridker PM, Cook NR, Pradhan AD. Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study). Am J Cardiol. 2015 Aug 15; 116(4):532-7. PMID: 26081066.
    Citations: 5     Fields:    Translation:Humans
  64. Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 2015 May 26; 131(21):1851-60. PMID: 25825410.
    Citations: 34     Fields:    Translation:HumansPHPublic Health
  65. Taqueti VR, Everett BM, Murthy VL, Gaber M, Foster CR, Hainer J, Blankstein R, Dorbala S, Di Carli MF. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35. PMID: 25480813.
    Citations: 39     Fields:    Translation:Humans
  66. Everett BM, Berger JS, Manson JE, Ridker PM, Cook NR. B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women. J Am Coll Cardiol. 2014 Oct 28; 64(17):1789-97. PMID: 25443700.
    Citations: 14     Fields:    Translation:Humans
  67. Khera AV, Everett BM, Caulfield MP, Hantash FM, Wohlgemuth J, Ridker PM, Mora S. Response to letter regarding article, "lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)". Circulation. 2014 Oct 21; 130(17):e152. PMID: 25332285.
    Citations: 1     Fields:    Translation:Humans
  68. Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB. Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetol. 2014 Dec; 51(6):1015-23. PMID: 25311055.
    Citations: 12     Fields:    Translation:Humans
  69. Everett BM, Mora S, Glynn RJ, MacFadyen J, Ridker PM. Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER). Am J Cardiol. 2014 Dec 01; 114(11):1682-9. PMID: 25439449.
    Citations: 15     Fields:    Translation:Humans
  70. Lubitz SA, Lunetta KL, Lin H, Arking DE, Trompet S, Li G, Krijthe BP, Chasman DI, Barnard J, Kleber ME, Dörr M, Ozaki K, Smith AV, Müller-Nurasyid M, Walter S, Agarwal SK, Bis JC, Brody JA, Chen LY, Everett BM, Ford I, Franco OH, Harris TB, Hofman A, Kääb S, Mahida S, Kathiresan S, Kubo M, Launer LJ, MacFarlane PW, Magnani JW, McKnight B, McManus DD, Peters A, Psaty BM, Rose LM, Rotter JI, Silbernagel G, Smith JD, Sotoodehnia N, Stott DJ, Taylor KD, Tomaschitz A, Tsunoda T, Uitterlinden AG, Van Wagoner DR, Völker U, Völzke H, Murabito JM, Sinner MF, Gudnason V, Felix SB, März W, Chung M, Albert CM, Stricker BH, Tanaka T, Heckbert SR, Jukema JW, Alonso A, Benjamin EJ, Ellinor PT. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014 Apr 01; 63(12):1200-1210. PMID: 24486271.
    Citations: 51     Fields:    Translation:HumansCells
  71. Khera AV, Everett BM, Caulfield MP, Hantash FM, Wohlgemuth J, Ridker PM, Mora S. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). Circulation. 2014 Feb 11; 129(6):635-42. PMID: 24243886.
    Citations: 71     Fields:    Translation:Humans
  72. Paynter NP, Everett BM, Cook NR. Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? Clin Chem. 2014 Jan; 60(1):88-97. PMID: 24100805.
    Citations: 10     Fields:    Translation:Humans
  73. Everett BM, Pradhan AD, Solomon DH, Paynter N, Macfadyen J, Zaharris E, Gupta M, Clearfield M, Libby P, Hasan AA, Glynn RJ, Ridker PM. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. Am Heart J. 2013 Aug; 166(2):199-207.e15. PMID: 23895801.
    Citations: 123     Fields:    Translation:Humans
  74. Everett BM, Cook NR, Conen D, Chasman DI, Ridker PM, Albert CM. Novel genetic markers improve measures of atrial fibrillation risk prediction. Eur Heart J. 2013 Aug; 34(29):2243-51. PMID: 23444395.
    Citations: 45     Fields:    Translation:Humans
  75. Everett BM, Cook NR, Chasman DI, Magnone MC, Bobadilla M, Rifai N, Ridker PM, Pradhan AD. Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women. Clin Chem. 2013 Mar; 59(3):557-65. PMID: 23288489.
    Citations: 9     Fields:    Translation:Humans
  76. Ridker PM, Howard CP, Walter V, Everett B, Libby P, Hensen J, Thuren T. Effects of interleukin-1ß inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012 Dec 04; 126(23):2739-48. PMID: 23129601.
    Citations: 153     Fields:    Translation:HumansCTClinical Trials
  77. Whang W, Davidson KW, Conen D, Tedrow UB, Everett BM, Albert CM. Global Psychological Distress and Risk of Atrial Fibrillation Among Women: The Women's Health Study. J Am Heart Assoc. 2012 Jun; 1(3):e001107. PMID: 23130138.
    Citations: 14     Fields:    
  78. Conen D, Everett BM, Kurth T, Creager MA, Buring JE, Ridker PM, Pradhan AD. Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med. 2011 Jun 07; 154(11):719-26. PMID: 21646555.
    Citations: 23     Fields:    Translation:Humans
  79. Everett BM, Cook NR, Magnone MC, Bobadilla M, Kim E, Rifai N, Ridker PM, Pradhan AD. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation. 2011 Jun 21; 123(24):2811-8. PMID: 21632491.
    Citations: 37     Fields:    Translation:Humans
  80. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011 May 25; 305(20):2080-7. PMID: 21610240.
    Citations: 104     Fields:    Translation:Humans
  81. Everett BM, Conen D, Buring JE, Moorthy MV, Lee IM, Albert CM. Physical activity and the risk of incident atrial fibrillation in women. Circ Cardiovasc Qual Outcomes. 2011 May; 4(3):321-7. PMID: 21487092.
    Citations: 27     Fields:    Translation:Humans
  82. Ahmad T, Chasman DI, Buring JE, Lee IM, Ridker PM, Everett BM. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry. Circ Cardiovasc Genet. 2011 Feb; 4(1):74-80. PMID: 21252145.
    Citations: 13     Fields:    Translation:Humans
  83. Kurtz EG, Ridker PM, Rose LM, Cook NR, Everett BM, Buring JE, Rexrode KM. Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause. 2011 Jan; 18(1):23-9. PMID: 20647959.
    Citations: 5     Fields:    Translation:Humans
  84. Conen D, Chiuve SE, Everett BM, Zhang SM, Buring JE, Albert CM. Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr. 2010 Sep; 92(3):509-14. PMID: 20573799.
    Citations: 21     Fields:    Translation:Humans
  85. Conen D, Ridker PM, Everett BM, Tedrow UB, Rose L, Cook NR, Buring JE, Albert CM. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010 Jul; 31(14):1730-6. PMID: 20501475.
    Citations: 35     Fields:    Translation:Humans
  86. Everett BM. Markers of mineral metabolism and cardiovascular disease. Ann Intern Med. 2010 May 18; 152(10):683-4. PMID: 20479031.
    Citations:    Fields:    Translation:Humans
  87. Everett BM. B-type natriuretic peptides and the promise of improved cardiovascular risk prediction. Clin Chem. 2010 Jun; 56(6):883-5. PMID: 20360124.
    Citations:    Fields:    Translation:Humans
  88. Johnson JA, Everett BM, Katz JT, Loscalzo J. Clinical problem-solving. Painful purple toes. N Engl J Med. 2010 Jan 07; 362(1):67-73. PMID: 20054049.
    Citations: 1     Fields:    Translation:Humans
  89. Everett BM, Glynn RJ, MacFadyen JG, Ridker PM. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation. 2010 Jan 05; 121(1):143-50. PMID: 20026779.
    Citations: 36     Fields:    Translation:Humans
  90. Ross JJ, Everett BM, Johnson JA, Miller A. Interactive Medical Case. Painful purple toes. N Engl J Med. 2009 Dec 17; 361(25):e58. PMID: 20050377.
    Citations:    Fields:    Translation:Humans
  91. Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM. Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. JAMA. 2009 Sep 16; 302(11):1186-94. PMID: 19755697.
    Citations: 40     Fields:    Translation:Humans
  92. Paynter NP, Cook NR, Everett BM, Sesso HD, Buring JE, Ridker PM. Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med. 2009 May; 122(5):464-71. PMID: 19375556.
    Citations: 12     Fields:    Translation:Humans
  93. Everett BM, Glynn RJ, Buring JE, Ridker PM. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. J Thromb Haemost. 2009 Apr; 7(4):588-96. PMID: 19187075.
    Citations: 9     Fields:    Translation:Humans
  94. Everett BM, Bansal S, Rifai N, Buring JE, Ridker PM. Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis. 2009 Jan; 202(1):282-8. PMID: 18514203.
    Citations: 12     Fields:    Translation:Humans
  95. Everett BM, Glynn RJ, Danielson E, Ridker PM. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial. Clin Ther. 2008 Apr; 30(4):661-72. PMID: 18498915.
    Citations: 7     Fields:    Translation:Humans
  96. Conen D, Everett BM, Glynn RJ, Ridker PM. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart. 2008 Mar; 94(3):e13. PMID: 17923463.
    Citations: 3     Fields:    Translation:Humans
  97. Everett B, Cameron B, Li H, Vollmer-Conna U, Davenport T, Hickie I, Wakefield D, Vernon S, Reeves WC, Lloyd AR. Polymorphisms in Toll-like receptors-2 and -4 are not associated with disease manifestations in acute Q fever. Genes Immun. 2007 Dec; 8(8):699-702. PMID: 17855803.
    Citations: 4     Fields:    Translation:Humans
  98. Ridker PM, Everett BM. Letter by Ridker and Everett regarding article, "The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?". Circulation. 2007 May 22; 115(20):e475; author reply e476. PMID: 17515471.
    Citations:    Fields:    Translation:Humans
  99. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology. 2007 Feb 20; 68(8):556-62. PMID: 17310025.
    Citations: 55     Fields:    Translation:Humans
  100. Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007 Feb; 83(2):592-7. PMID: 17257993.
    Citations: 10     Fields:    Translation:Humans
  101. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol. 2006 Dec 05; 48(11):2235-42. PMID: 17161253.
    Citations: 36     Fields:    Translation:Humans
  102. Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J. 2006 Aug; 152(2):290.e1-7. PMID: 16875910.
    Citations: 2     Fields:    Translation:Humans
  103. Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization. Am J Cardiol. 2006 Aug 01; 98(3):419-21. PMID: 16860036.
    Citations:    Fields:    Translation:Humans
  104. Low AF, O'Donnell CJ, Kathiresan S, Everett B, Chae CU, Shaw SY, Ellinor PT, MacRae CA. Aging syndrome genes and premature coronary artery disease. BMC Med Genet. 2005 Oct 31; 6:38. PMID: 16262891.
    Citations: 11     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Everett's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (322)
Co-Authors (75)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.